Our unique TrialMax™ eDiary design tool has been developed specifically to provide rich functionality. It enables clinical trial sponsors to collect primary and secondary efficacy data in shorter timescales and to conduct complex clinical trials with greater flexibility than any other ePRO solution.
The individual components of TrialMax™ provide a comprehensive suite of tools to design, manage and host global ePRO studies in phases I to IV via mobile PDA devices, mobile phones and the Internet.
Already used by more than 105,000 patients across 55 countries in 52 languages for 45 indications, an eDiary solution from CRF can deliver studies from 50 to 15,000 patients, across 2 to 200 sites and user acceptance from children to the elderly and terminally ill.
As your data standards are built
into the TrialMax™ data model, the eDiary
data format will match the format of all your other
trial data. On-line transfer ensures that data can
be accessed when required; standard and customized
reports are readily available.
The old methodology of designing eDiaries –
manually programming each study into a PDA device
– is time-consuming, error-prone and inflexible,
and does not allow the level of collaboration with
the clinical study teams that is necessary to gain
the true benefit’s of eDiaries in a clinical
trial.
TrialMax™ eliminates the error-prone manual
processes, providing more flexibility, more time
to design effective eDiaries and the potential for
more detailed yet simpler to use eDiaries, all of
which result in improved data accuracy and a typical
compliance rate of 95%.
16 of the World’s top 20 pharmaceutical companies
trust CRF to provide their ePRO solutions, so why
don’t you strengthen your claims and submissions
with an eDiary solution from CRF?
